Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8092499 | 0.89 | TSHR (0.42) | TSHRCHRM2CHRM1MEN1CYP2D6 | |
| SCHEMBL27809329 | 0.77 | — | — | |
| SCHEMBL3641088 | 0.72 | — | — | |
| SCHEMBL11637458 | 0.70 | CHRM2 (0.33) | CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL19365113 | 0.70 | TSHR (0.48) | TSHRCHRM2CHRM1MEN1CYP2D6 | |
| SCHEMBL24884685 | 0.69 | EPHX1 (0.36) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL18236939 | 0.69 | EPHX1 (0.36) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL868024 | 0.69 | EPHX1 (0.36) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL20839586 | 0.69 | EPHX1 (0.36) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL868023 | 0.69 | EPHX1 (0.36) | CHRM2CHRM1MEN1CYP2D6KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140219925-A1 | POLYMER PARTICLES OR NANO-VECTORS AND USE THEREOF AS A DRUG AND/OR DIAGNOSTIC AGENT | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2014-08-07 | — | — | US | claimed |
| EP-1771492-B1 | STIMULATEABLE POLYMER PARTICLES EXHIBITING REACTIVE FUNCTIONS, METHOD FOR THE PRODUCTION AND THE USE THEREOF | CENTRE NAT RECH SCIENT (FR) | 2010-11-10 | — | — | EP | claimed |
| EP-1758621-B1 | BIOACTIVE BIOMATERIALS FOR CONTROLLED DELIVERY OF ACTIVE PRINCIPLES | CENTRE NAT RECH SCIENT (FR) | 2010-08-11 | — | — | EP | claimed |
| US-20090123555-A1 | Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof | CENTRE NATIONAL DE LA RECHER CHE SCIENTIFIQUE (FR) | 2009-05-14 | — | — | US | claimed |
| US-20080004398-A1 | Bioactive Biomaterials for Controlled Delivery of Active Principles | UNIVERSITE DE BORDEAUX I (FR) | 2008-01-03 | — | — | US | claimed |
| US-20170360947-A1 | POLYMER PARTICLES AND BIOMATERIALS COMPRISING THE SAME | Universite de Bordeaux (FR) | 2017-12-21 | — | — | US | disclosed |
| EP-3237488-A1 | POLYMER PARTICLES AND BIOMATERIALS COMPRISING THE SAME | Université de Bordeaux (FR) | 2017-11-01 | — | — | EP | disclosed |
| WO-2016097358-A1 | POLYMER PARTICLES AND BIOMATERIALS COMPRISING THE SAME | Universite de Bordeaux (FR) | 2016-06-23 | — | — | WO | disclosed |
| EP-3034538-A1 | Polymer particles and biomaterials comprising the same | UNIVERSITE DE BORDEAUX (FR) | 2016-06-22 | — | — | EP | disclosed |
| US-20140219925-A1 | POLYMER PARTICLES OR NANO-VECTORS AND USE THEREOF AS A DRUG AND/OR DIAGNOSTIC AGENT | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2014-08-07 | — | — | US | disclosed |
| US-20090123555-A1 | Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof | CENTRE NATIONAL DE LA RECHER CHE SCIENTIFIQUE (FR) | 2009-05-14 | — | — | US | disclosed |
| US-20080004398-A1 | Bioactive Biomaterials for Controlled Delivery of Active Principles | UNIVERSITE DE BORDEAUX I (FR) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360947-A1 | POLYMER PARTICLES AND BIOMATERIALS COMPRISING THE SAME | CD47, INCENP, BAG6 | TSHR 4816/4885CHRM2 4422/4885CHRM1 4313/4885 |
| US-20140219925-A1 | POLYMER PARTICLES OR NANO-VECTORS AND USE THEREOF AS A DRUG AND/OR DIAGNOSTIC AGENT | ABCB1, TSG101, CD44 | TSHR 3386/4885CHRM2 4761/4885CHRM1 4775/4885 |
| US-20090123555-A1 | Stimulateable Polymer Particles Exhibiting Reactive Functions, Method for the Production and the Use Thereof | PMAIP1, ACP1, CD40 | TSHR 1511/4885CHRM2 1280/4885CHRM1 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.